Egyptian International Pharmaceutical Investments (CAI:PHAR) ROCE % : 25.21% (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Egyptian International Pharmaceutical Investments's annualized ROCE % for the quarter that ended in Sep. 2024 was 25.21%.

Egyptian International Pharmaceutical Investments ROCE % Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments ROCE % Chart

Egyptian International Pharmaceutical Investments Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

22.31

22.96

26.02

26.14

Egyptian International Pharmaceutical Investments Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															19.50	20.37	40.97	24.77	25.21

Egyptian International Pharmaceutical Investments ROCE % Calculation

Egyptian International Pharmaceutical Investments's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1471.78	/	( ( (6773.91 - 2659.657)	+	(9978.783 - 2830.735) )	/ 2 )
	=	1471.78	/	( (4114.253	+	7148.048)	/ 2 )
	=	1471.78	/	5631.1505
	=	26.14 %

Egyptian International Pharmaceutical Investments's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	2360.016	/	( ( (13901.658 - 4658.721)	+	(14704.193 - 5223.718) )	/ 2 )
	=	2360.016	/	( ( 9242.937	+	9480.475 )	/ 2 )
	=	2360.016	/	9361.706
	=	25.21 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Egyptian International Pharmaceutical Investments (CAI:PHAR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Egyptian International Pharmaceutical Investments ROCE % Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Egyptian International Pharmaceutical Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, P.O. Box 149 10th, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.